HIMX [Himax Technologies] 20-F: (Original Filing)

[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6 ITEM 3. KEY INFORMATION 6 3.A. Selected Financial Data 6 3.B. Capitalization and Indebtedness 8 3.C. Reason for the Offer and Use of Proceeds 8 3.D. Risk Factors 9 ITEM 4.] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 15, 2015 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements (No. 333-137585 and No. 333-176863) on Form S-8 and the registration statements (No. 333-188253 and No. 333-189052) on Form F-3 of Himax Technologies, Inc. and subsidiaries of our reports dated April 15, 2015, with respect to the consolidated]

By | 2016-03-15T23:10:12+00:00 April 15th, 2015|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE LETTER DUE TO DELAY IN FILING FORM 10-K Xi’an, China, April 15, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it] [805 King Farm Blvd. Rockville, MD 20850 / USA Nasdaq.com By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com April 15, 2015 Mr. Bing Mei Chief Financial Officer Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Shaanxi Province, P.R. China Re: Skystar Bio-Pharmaceutical Company (the “Company”) Nasdaq Symbol: SKBI Dear Mr. Mei: 1 I am] []

By | 2016-03-27T15:23:59+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

MPEL [Melco Crown Entertainment] 6-K: THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE

[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (SEHK Stock Code: 6883) PROPOSALS FOR (1) RE-ELECTION AND APPOINTMENT OF DIRECTORS, (2) GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, (3) AMENDMENTS TO SHARE] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED]

By | 2016-03-30T01:02:54+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] 20-F: TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4

[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6 ITEM 3. KEY INFORMATION 6 3.A. Selected Financial Data 6 3.B. Capitalization and Indebtedness 8 3.C. Reason for the Offer and Use of Proceeds 8 3.D. Risk Factors 9 ITEM 4.] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 15, 2015 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements (No. 333-137585 and No. 333-176863) on Form S-8 and the registration statements (No. 333-188253 and No. 333-189052) on Form F-3 of Himax Technologies, Inc. and subsidiaries of our reports dated April 15, 2015, with respect to the consolidated]

By | 2016-03-15T23:11:43+00:00 April 15th, 2015|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 20-F: (Original Filing)

[CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and Supplemental Information 2 2 Part I Item 1. Identity of Directors, Senior Management and Advisers 4 Item 2. Offer Statistics and Expected Timetable 4 Item 3. Key Information 4 Item 4. Information on the Company 22 Item 4A. Unresolved Staff Comments 38 Item 5. Operating and Financial Review and Prospects 38 Item] [The particulars of the Company’s subsidiaries as at December 31, 2014 are set forth below: Attributable equity interests Name of company Jurisdiction Direct Indirect Guangxi Yuchai Machinery Company Limited People’s Republic of — 76.4 % Guangxi Yuchai Accessories Manufacturing Company Limited PRC — 76.4 % Guangxi Yulin Yuchai Accessories Manufacturing Company Limited PRC — 74.2 % Guangxi Yuchai Machinery Monopoly] [TO SECTION 302 OF THE SARBANES-OXLEY ACT I, Hoh Weng Ming, certify that: 1. I have reviewed this annual report on Form 20-F of China Yuchai International Limited (the “Company”); 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [Consent of Independent Registered Public Accountant Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-197287) pertaining to the Equity Incentive Plan of China Yuchai International Limited of our reports dated April 15, 2015, with respect to the consolidated financial statements of China Yuchai International Limited and the effectiveness of internal control over financial]

By | 2016-03-28T12:29:40+00:00 April 15th, 2015|Categories: Chinese Stocks, CYD, SEC Original|Tags: , , , , , |0 Comments

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[Melco Crown Entertainment ANNUAL REPORT 2014 MELCO CROWN ENTERTAINMENT LIMITED and NASDAQ (Symbol: MPEL) (Incorporated in the Cayman Islands with limited liability) THE HOUSE of DANCING WATER CITY OF DREAMS A premier leisure and entertainment destination in Macau that offers the ultimate in innovative, highly contemporary and world-class leisure experiences that appeal to the rapidly evolving demands of the Asian-leisure] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA]

By | 2016-03-30T01:12:13+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Provides Updates on Pipeline Vaccines BEIJING, March 17, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. ), a leading provider of biopharmaceutical products in China, today provided updates on the Company's pipeline vaccines. EV71 vaccine. EV71 is a virus that causes hand, foot and mouth disease (HFMD) and is the primary cause of most severe and fatal cases of hand, foot] [Sinovac to Participate in China Medical and Healthcare Investment Conference Beijing, March 18,2014/PRNewswire/--Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in the China Medical and Healthcare Investment Conference sponsored by T.H capital and Dong Xing Security, to be held at China World Hotel from March 23 to March 25. The] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results BEIJING, April 10, 2015 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and full year, ended December 31, 2014, before market opens on Monday,] []

By | 2016-03-16T06:47:01+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 20-F: CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and

[CHINA YUCHAI INTERNATIONAL LIMITED Page Certain Definitions and Supplemental Information 2 2 Part I Item 1. Identity of Directors, Senior Management and Advisers 4 Item 2. Offer Statistics and Expected Timetable 4 Item 3. Key Information 4 Item 4. Information on the Company 22 Item 4A. Unresolved Staff Comments 38 Item 5. Operating and Financial Review and Prospects 38 Item] [The particulars of the Company’s subsidiaries as at December 31, 2014 are set forth below: Attributable equity interests Name of company Jurisdiction Direct Indirect Guangxi Yuchai Machinery Company Limited People’s Republic of — 76.4 % Guangxi Yuchai Accessories Manufacturing Company Limited PRC — 76.4 % Guangxi Yulin Yuchai Accessories Manufacturing Company Limited PRC — 74.2 % Guangxi Yuchai Machinery Monopoly] [TO SECTION 302 OF THE SARBANES-OXLEY ACT I, Hoh Weng Ming, certify that: 1. I have reviewed this annual report on Form 20-F of China Yuchai International Limited (the “Company”); 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. TO SECTION 906 OF THE SARBANES-OXLEY ACT (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [Consent of Independent Registered Public Accountant Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-197287) pertaining to the Equity Incentive Plan of China Yuchai International Limited of our reports dated April 15, 2015, with respect to the consolidated financial statements of China Yuchai International Limited and the effectiveness of internal control over financial]

By | 2016-03-28T12:30:47+00:00 April 15th, 2015|Categories: Chinese Stocks, CYD, Webplus ver|Tags: , , , , , |0 Comments

MPEL [Melco Crown Entertainment] 6-K: Melco Crown Entertainment ANNUAL REPORT 2014 MELCO CROWN

[Melco Crown Entertainment ANNUAL REPORT 2014 MELCO CROWN ENTERTAINMENT LIMITED and NASDAQ (Symbol: MPEL) (Incorporated in the Cayman Islands with limited liability) THE HOUSE of DANCING WATER CITY OF DREAMS A premier leisure and entertainment destination in Macau that offers the ultimate in innovative, highly contemporary and world-class leisure experiences that appeal to the rapidly evolving demands of the Asian-leisure] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA]

By | 2016-03-30T01:13:18+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Provides Updates on Pipeline Vaccines BEIJING, March

[Sinovac Provides Updates on Pipeline Vaccines BEIJING, March 17, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. ), a leading provider of biopharmaceutical products in China, today provided updates on the Company's pipeline vaccines. EV71 vaccine. EV71 is a virus that causes hand, foot and mouth disease (HFMD) and is the primary cause of most severe and fatal cases of hand, foot] [Sinovac to Participate in China Medical and Healthcare Investment Conference Beijing, March 18,2014/PRNewswire/--Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in the China Medical and Healthcare Investment Conference sponsored by T.H capital and Dong Xing Security, to be held at China World Hotel from March 23 to March 25. The] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results BEIJING, April 10, 2015 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and full year, ended December 31, 2014, before market opens on Monday,] []

By | 2016-03-16T06:47:56+00:00 April 15th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar